The Alliance Long COVID-19 Treatment Trial

The Alliance Long COVID-19 Treatment Trial

Development of a 2-stage nutraceutical treatment protocol for adults with long-COVID-19 syndrome, exploring underlying pathophysiology and treatment effectiveness

The study has been approved by the Human Research Ethics Commitee EC00436, and is registered at the ANZCTR clinical trial registry: ACTRN12622001204730p

Project explanation and objectives

A large number of people experience long-COVID symptoms persisting for weeks and months after overcoming the acute illness. Symptoms include chronic fatigue, breathlessness, joint pain, cough, neurological diseases, loss of sense of smell and/or taste

This cohort study aims to explore the underlying causes of long COVID symptoms, and assess treatment effectiveness of a staged treatment approach of 2x 6 weeks.
This study is exploratory, and will provide important insights for protocol development for a larger cohort study.

Who can participate in this study?

You had Covid-19 and tested positive on a PCR or RAT test more than 3 months ago, and have persistent symptoms for longer than 3 months, and have a doctor’s referral.

The study involves:

  • A series of online questionnaires focusing on your symptoms and medical history
  • 3 appointments with the trial doctor over a period of 3 months
  • Blood tests at baseline and 12 weeks include standard pathology tests and the NIIM Rare Cell & Pathogen Test
  • After review of the blood test results, the trial doctor will refer you to Stage 1 intervention (0-6 weeks):
    The first 6 weeks’ treatment period will be the same for all participants, and includes food-based nutrients and supplements.
  • At 6 week assessment by online questionnaire and the trial doctor. The trial doctor will allocate you to one in three intervention groups.
  • Group 1: Intravenous Vitamin C therapy (IVC) – NIIM Clinic in Melbourne, VIC
  • Group 2: Kyolic & Curcumin & Omega-3 & NAC (N-acetyl-cysteine)
  • Group 3: Continuation of the food-based nutritional protocol
  • Final assessment by online questionnaire and trial doctor at 12 weeks

10.12.22 update: Expressions of Interest for the Long-COVID-Trial have now closed.
If you are interested in making an appointment with a NIIM doctor specialising in Long-COVID, please ring the NIIM clinic on 03 9804 0646

Unlocking Nature’s Secret: How Phytoestrogens Can Ease Your Menopause Journey

Unlocking Nature’s Secret: How Phytoestrogens Can Ease Your Menopause Journey

If you’re a woman in your mid-40’s to mid-50’s experiencing night sweats, hot flushes, mood swings, insomnia, unexplained weight gain, irregular periods and abnormally heavy periods, you may be peri menopausal.

Read More
Seasonal Allergies

Seasonal Allergies

As we head into Spring, many of us will be anticipating the return of hay fever and allergies. Allergies emerge when your immune system responds to substances, e.g. pollens or certain foods, by treating them as a foreign pathogen.

Read More

More Studies We're Conducting

New Studies Seeking participants

Rife Frequency Study

This study uses Electro-Magnetic-Frequency Therapy (EMF), for the treatment of cancer and/or pathogens, and Circulating Tumour Cell (CTC) blood testing to assess EMF treatment effectiveness.

New Studies Not taking participants

The Cognitive Preservation Study

This study aims to analyse the effect of Red Light Therapy, with or without additional Hyperbaric Oxygen Therapy, on cognition and brain health in people with mild and moderate cognitive impairment.

Past Studies Not taking participants

The Gluco-Metabolism Study

12-week randomised placebo-controlled trial investigating the tolerability and effectiveness of the Nutrition Care Gluco-Metabolism herbal Formula on blood glucose levels.